Published in Mol Cell Biol on August 01, 2000
Evolution of the cancer genome. Nat Rev Genet (2012) 3.24
Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev (2001) 3.16
Cellular senescence and its effector programs. Genes Dev (2014) 2.37
ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescence. Oncogene (2011) 1.45
Normal human fibroblasts are resistant to RAS-induced senescence. Mol Cell Biol (2004) 1.30
Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization. Am J Pathol (2005) 1.18
Telomere and telomerase in the initial stage of immortalization of esophageal epithelial cell. World J Gastroenterol (2002) 1.12
Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations. BMC Cancer (2009) 0.86
Macrophages, nitric oxide and microRNAs are associated with DNA damage response pathway and senescence in inflammatory bowel disease. PLoS One (2012) 0.85
Progressive transformation of immortalized esophageal epithelial cells. World J Gastroenterol (2002) 0.84
Umbilical cord mesenchymal stromal cells affected by gestational diabetes mellitus display premature aging and mitochondrial dysfunction. Stem Cells Dev (2015) 0.82
Long-term quiescent fibroblast cells transit into senescence. PLoS One (2014) 0.77
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A (1995) 32.89
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell (1997) 29.13
Specific association of human telomerase activity with immortal cells and cancer. Science (1994) 28.20
CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev (1999) 24.83
ras oncogenes in human cancer: a review. Cancer Res (1989) 22.03
Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res (1990) 20.53
Extension of life-span by introduction of telomerase into normal human cells. Science (1998) 20.48
The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature (1999) 12.60
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell (1988) 10.29
Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science (1995) 9.79
Prevalence of ras gene mutations in human colorectal cancers. Nature (1987) 9.23
Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell (1996) 8.77
A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell (1996) 8.41
Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature (1998) 7.81
Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell (1996) 7.69
Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev (1998) 5.60
Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev (1997) 5.49
The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J (1999) 5.44
p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr Biol (1999) 5.40
Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev (1998) 5.14
Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science (1997) 4.97
p19ARF links the tumour suppressor p53 to Ras. Nature (1998) 4.89
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature (1995) 4.78
Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J (1997) 4.17
Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci U S A (1995) 3.79
Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature (1998) 3.67
Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res (1995) 3.16
Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature (1997) 2.78
Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol Cell Biol (1998) 2.64
p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol (1999) 2.47
Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nat Genet (2000) 2.26
High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene (1989) 1.98
Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts. Cancer Res (1999) 1.86
Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells. Cancer Res (1996) 1.65
p27Kip1 alters the response of cells to mitogen and is part of a cell-intrinsic timer that arrests the cell cycle and initiates differentiation. Curr Biol (1998) 1.61
Cellular senescence and cancer. J Pathol (1999) 1.57
DNA damage and repair in telomeres: relation to aging. Proc Natl Acad Sci U S A (1995) 1.56
Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation. Oncogene (1998) 1.52
Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene (1994) 1.48
Ras-stimulated extracellular signal-related kinase 1 and RhoA activities coordinate platelet-derived growth factor-induced G1 progression through the independent regulation of cyclin D1 and p27. J Biol Chem (1997) 1.47
Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts. Mol Cell Biol (1997) 1.47
Loss of p16INK4 expression by methylation is associated with lifespan extension of human mammary epithelial cells. Cancer Res (1998) 1.45
p16INK4a, but not constitutively active pRb, can impose a sustained G1 arrest: molecular mechanisms and implications for oncogenesis. Oncogene (1999) 1.42
Presence of mutations in all three ras genes in human thyroid tumors. Oncogene (1990) 1.42
Geranylgeranylated rho small GTPase(s) are essential for the degradation of p27Kip1 and facilitate the progression from G1 to S phase in growth-stimulated rat FRTL-5 cells. J Biol Chem (1997) 1.38
Overcoming cellular senescence in human cancer pathogenesis. Genes Dev (1998) 1.36
Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway. Oncogene (1997) 1.24
Control of replicative life span in human cells: barriers to clonal expansion intermediate between M1 senescence and M2 crisis. Mol Cell Biol (1999) 1.23
Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors. Mod Pathol (1998) 1.21
Reinitiation of DNA synthesis and cell division in senescent human fibroblasts by microinjection of anti-p53 antibodies. Mol Cell Biol (1998) 1.19
Induction of p21(WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a). Mol Cell Biol (1999) 1.17
Aberrant p27kip1 expression in endocrine and other tumors. Am J Pathol (1997) 1.17
The role of cell cycle regulatory proteins, cyclin D1, cyclin E, and p27 in thyroid carcinogenesis. Hum Pathol (1998) 1.16
Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories. Am J Surg Pathol (1999) 1.10
RhoA stimulates p27(Kip) degradation through its regulation of cyclin E/CDK2 activity. J Biol Chem (1999) 1.06
Ras versus cyclin-dependent kinase inhibitors. Curr Opin Genet Dev (1998) 0.99
p27Kip1 is expressed transiently in developing myotomes and enhances myogenesis. Cell Growth Differ (1998) 0.97
A reassessment of the telomere hypothesis of senescence. Bioessays (1998) 0.97
In vitro reconstruction of tumour initiation in a human epithelium. Oncogene (1994) 0.97
Loss of dependence on IGF-1 for proliferation of human thyroid adenoma cells. Br J Cancer (1988) 0.93
A requirement for cyclin D3-cyclin-dependent kinase (cdk)-4 assembly in the cyclic adenosine monophosphate-dependent proliferation of thyrocytes. J Cell Biol (1998) 0.89
Expression of p27Kip1 in osteoblast-like cells during differentiation with parathyroid hormone. Endocrinology (1997) 0.88
Activation of mitogen-activated protein kinase is necessary but not sufficient for proliferation of human thyroid epithelial cells induced by mutant Ras. Oncogene (1999) 0.87
Partial transformation of human thyroid epithelial cells by mutant Ha-ras oncogene. Oncogene (1990) 0.84
Spontaneous de-differentiation correlates with extended lifespan in transformed thyroid epithelial cells: an epigenetic mechanism of tumour progression? Int J Cancer (1996) 0.83
Dissociation of telomere dynamics from telomerase activity in human thyroid cancer cells. Exp Cell Res (1998) 0.82
A telomere-independent senescence mechanism is the sole barrier to Syrian hamster cell immortalization. Oncogene (1998) 0.81
Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours. Oncogene (1998) 0.78
Endless quest. Bioessays (1996) 0.77
Abnormalities of the P16INK4A gene in thyroid cancer cell lines. Eur J Cancer (1996) 0.77
High frequency deletion of the tumour suppressor gene P16INK4a (MTS1) in human thyroid cancer cell lines. Mol Cell Endocrinol (1996) 0.77
Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol (2000) 9.16
Generation and analysis of 280,000 human expressed sequence tags. Genome Res (1996) 8.27
The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature (2001) 6.73
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature (1995) 4.78
Rapid destruction of human Cdc25A in response to DNA damage. Science (2000) 4.74
Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet (1990) 4.49
Repression of p15INK4b expression by Myc through association with Miz-1. Nat Cell Biol (2001) 4.22
Measures of concurrency in networks and the spread of infectious disease. Math Biosci (1996) 3.96
Centrosome duplication in mammalian somatic cells requires E2F and Cdk2-cyclin A. Nat Cell Biol (1999) 3.74
Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res (1994) 3.65
A pooled analysis of magnetic fields and childhood leukaemia. Br J Cancer (2000) 3.49
Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO J (1999) 3.41
Cellular senescence in naevi and immortalisation in melanoma: a role for p16? Br J Cancer (2006) 3.23
High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res (1996) 3.18
Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol Cell Biol (1995) 3.16
Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization. EMBO J (1999) 3.05
Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev (1997) 3.02
Cell cycle analysis and chromosomal localization of human Plk1, a putative homologue of the mitotic kinases Drosophila polo and Saccharomyces cerevisiae Cdc5. J Cell Sci (1994) 3.00
P53 in tumour pathology: can we trust immunocytochemistry? J Pathol (1992) 3.00
Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts. J Cell Biol (1993) 2.83
Cyclin D1 protein expression and function in human breast cancer. Int J Cancer (1994) 2.81
Significance of crystal clear urine. Lancet (1990) 2.81
Both positive and negative regulators of HO transcription are required for mother-cell-specific mating-type switching in yeast. Cell (1987) 2.80
von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. Hum Mol Genet (2001) 2.79
Plasma oxytocin levels in autistic children. Biol Psychiatry (1998) 2.77
Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia. AIDS Care (2008) 2.73
Factors influencing stethoscope cleanliness among clinical medical students. J Hosp Infect (2013) 2.67
Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex. Nature (1999) 2.63
Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cell Dev Biol Anim (1995) 2.63
A microRNA component of the hypoxic response. Cell Death Differ (2008) 2.59
The psychosocial benefits of corrective surgery for adults with strabismus. Br J Ophthalmol (2006) 2.44
Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol Cell Biol (1996) 2.44
American legislation on AIDS. BMJ (1991) 2.43
The inhibition of staphylococcal beta-lactamase by clavulanic acid. Biochem J (1979) 2.30
Induction of S-phase entry by E2F transcription factors depends on their nuclear localization. Mol Cell Biol (1997) 2.27
Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nat Genet (2000) 2.26
Basecalling with LifeTrace. Genome Res (2001) 2.18
DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J Cell Biol (1994) 2.11
Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene (1994) 2.10
Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci U S A (1994) 2.09
Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase). J Cell Biol (1994) 2.08
Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium. J Cell Sci (1989) 2.07
High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene (1989) 1.98
MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene (2010) 1.97
Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes. EMBO J (1995) 1.92
The histological classification of duodenitis in fibreoptic biopsy specimens. Digestion (1975) 1.89
Lysosomal changes in epithelial cells of the mouse thymus after hydrocortisone treatment. Histochemie (1969) 1.84
Infant mortality from spina bifida, congenitalhydrocephalus, monstrosity, and congenital dseases of the cardiovascular system in England and Wales. Ann Hum Genet (1971) 1.83
Role of the site of protonation in the low-energy decompositions of gas-phase peptide ions. J Am Soc Mass Spectrom (1996) 1.83
Rapid X-ray flaring from the direction of the supermassive black hole at the Galactic Centre. Nature (2001) 1.78
Role of catechol siderophore synthesis in Vibrio vulnificus virulence. Infect Immun (1996) 1.78
Oxytocin and autistic disorder: alterations in peptide forms. Biol Psychiatry (2001) 1.77
Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint. Mol Cell Biol (1996) 1.75
Concurrent partnerships and syphilis persistence: new thoughts on an old puzzle. Sex Transm Dis (2001) 1.75
Nonperiodic activity of the human anaphase-promoting complex-Cdh1 ubiquitin ligase results in continuous DNA synthesis uncoupled from mitosis. Mol Cell Biol (2000) 1.74
Efficient algorithms for molecular sequence analysis. Proc Natl Acad Sci U S A (1988) 1.72
The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas. Int J Cancer (1994) 1.71
The phenomenon of "picky eater": a behavioral marker in eating patterns of toddlers. J Am Coll Nutr (1998) 1.69
Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res (1995) 1.68
Characterisation of human thyroid epithelial cells immortalised in vitro by simian virus 40 DNA transfection. Br J Cancer (1989) 1.68
Identity of some human bladder cancer cell lines. Nature (1983) 1.65
Three-dimensional cellular development is essential for ex vivo formation of human bone. Nat Biotechnol (2000) 1.62
The CHEK2 gene and inherited breast cancer susceptibility. Oncogene (2006) 1.62
Substrate specificity and cell cycle regulation of the Nek2 protein kinase, a potential human homolog of the mitotic regulator NIMA of Aspergillus nidulans. J Biol Chem (1995) 1.61
Centralisation of oesophageal cancer services; the view from the periphery. J R Coll Surg Edinb (2000) 1.58
Practice makes perfect: developing public health practice. J Epidemiol Community Health (1999) 1.58
Patterns of expression of keratin 19 as detected with monoclonal antibodies in human breast tissues and tumours. Int J Cancer (1985) 1.57
The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res (1996) 1.55
Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and an AVID substudy. Antiarrhythmics Versus Implantable Defibrillators. J Cardiovasc Electrophysiol (2001) 1.55
Immune-complex mediated colitis in rabbits. An experimental model. Gut (1978) 1.54
What outcomes from pharmacologic treatments are important to people with rheumatoid arthritis? Creating the basis of a patient core set. Arthritis Care Res (Hoboken) (2010) 1.53
Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease--a population-based study. Aliment Pharmacol Ther (2011) 1.53
A conserved cyclin-binding domain determines functional interplay between anaphase-promoting complex-Cdh1 and cyclin A-Cdk2 during cell cycle progression. Mol Cell Biol (2001) 1.53
Unwelcome customers? The epidemiology of removal from general practitioner lists in Sheffield. Br J Gen Pract (1998) 1.52
Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation. Oncogene (1998) 1.52
Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas. Oncogene (2010) 1.52
Intracranial Pressure Monitoring: Invasive versus Non-Invasive Methods-A Review. Crit Care Res Pract (2012) 1.51
Asthma induced by cold air and its relation to nonspecific bronchial responsiveness to methacholine. Am Rev Respir Dis (1982) 1.51
Diphosphonate therapy of paget's disease of bone. J Clin Endocrinol Metab (1977) 1.50
Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblasts. J Biol Chem (1996) 1.50
Bulky endocervical carcinoma: a 23-year experience. Int J Radiat Oncol Biol Phys (1992) 1.49
Comparison of the human and mouse genes encoding the telomeric protein, TRF1: chromosomal localization, expression and conserved protein domains. Hum Mol Genet (1997) 1.48
Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene (1994) 1.48
Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer. Cancer Lett (1995) 1.48
Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage. Mol Cell Biol (2000) 1.46
AMA rejects compulsory HIV testing. BMJ (1991) 1.46
DNA damage-activated kinase Chk2 is independent of proliferation or differentiation yet correlates with tissue biology. Cancer Res (2001) 1.46
Activated ras oncogenes in human thyroid cancers. Cancer Res (1988) 1.45
Recombination and RNA processing: a common strand? Trends Cell Biol (1991) 1.43
Groin dissection practices among gynecologic oncologists treating early vulvar cancer. Gynecol Oncol (1996) 1.43
p16INK4a, but not constitutively active pRb, can impose a sustained G1 arrest: molecular mechanisms and implications for oncogenesis. Oncogene (1999) 1.42
Reluctance to undergo predictive testing: the case of Huntington disease. Am J Med Genet (1993) 1.42
Hypervariable lengths of human DNA associated with a human satellite III sequence found in the 3.4kb Y-specific fragment. Nucleic Acids Res (1987) 1.41
Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol Oncol (2000) 1.41